83 related articles for article (PubMed ID: 12110530)
1. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans.
Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E259-66. PubMed ID: 12110530
[TBL] [Abstract][Full Text] [Related]
2. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk WF; Rizza RA
Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.
Basu A; Basu R; Shah P; Vella A; Johnson CM; Jensen M; Nair KS; Schwenk WF; Rizza RA
Diabetes; 2001 Jun; 50(6):1351-62. PubMed ID: 11375336
[TBL] [Abstract][Full Text] [Related]
4. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.
Shah P; Vella A; Basu A; Basu R; Adkins A; Schwenk WF; Johnson CM; Nair KS; Jensen MD; Rizza RA
Diabetes; 2002 Feb; 51(2):301-10. PubMed ID: 11812736
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA
Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
[TBL] [Abstract][Full Text] [Related]
7. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia.
Zangeneh F; Basu R; Shah P; Arora P; Camilleri M; Rizza RA
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E280-6. PubMed ID: 12857674
[TBL] [Abstract][Full Text] [Related]
8. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
Kiwanuka E; Barazzoni R; Tessari P
Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
Vella A; Shah P; Reed AS; Adkins AS; Basu R; Rizza RA
Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans.
Féry F; Tappy L; Devière J; Balasse EO
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E176-83. PubMed ID: 14532166
[TBL] [Abstract][Full Text] [Related]
11. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.
Vella A; Reed AS; Charkoudian N; Shah P; Basu R; Basu A; Joyner MJ; Rizza RA
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E25-30. PubMed ID: 12637258
[TBL] [Abstract][Full Text] [Related]
12. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.
Adkins A; Basu R; Persson M; Dicke B; Shah P; Vella A; Schwenk WF; Rizza R
Diabetes; 2003 Sep; 52(9):2213-20. PubMed ID: 12941759
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic and extrasplanchnic extraction of insulin following oral and intravenous glucose loads.
Brundin T
Clin Sci (Lond); 1999 Oct; 97(4):429-36. PubMed ID: 10491343
[TBL] [Abstract][Full Text] [Related]
14. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
[TBL] [Abstract][Full Text] [Related]
15. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
[TBL] [Abstract][Full Text] [Related]
16. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man.
Krebs M; Brunmair B; Brehm A; Artwohl M; Szendroedi J; Nowotny P; Roth E; Fürnsinn C; Promintzer M; Anderwald C; Bischof M; Roden M
Diabetes; 2007 Jun; 56(6):1600-7. PubMed ID: 17329620
[TBL] [Abstract][Full Text] [Related]
17. Contribution of net hepatic glycogen synthesis to disposal of an oral glucose load in humans.
Petersen KF; Cline GW; Gerard DP; Magnusson I; Rothman DL; Shulman GI
Metabolism; 2001 May; 50(5):598-601. PubMed ID: 11319724
[TBL] [Abstract][Full Text] [Related]
18. Alterations in carbohydrate metabolism in response to short-term dietary carbohydrate restriction.
Harber MP; Schenk S; Barkan AL; Horowitz JF
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E306-12. PubMed ID: 15797987
[TBL] [Abstract][Full Text] [Related]
19. Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs.
Nishizawa M; Moore MC; Shiota M; Gustavson SM; Snead WL; Neal DW; Cherrington AD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1027-36. PubMed ID: 12569088
[TBL] [Abstract][Full Text] [Related]
20. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.
Basu A; Basu R; Shah P; Vella A; Johnson CM; Nair KS; Jensen MD; Schwenk WF; Rizza RA
Diabetes; 2000 Feb; 49(2):272-83. PubMed ID: 10868944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
